NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES



TORONTO, Oct. 23, 2018 (GLOBE NEWSWIRE) -- Canada House Wellness Group Inc (“Canada House” or the “Company”) (CSE: CHV) would like to remind its shareholders of its Annual General and Special Meeting of Shareholders (the “Meeting”) which will be held on Tuesday October 30, 2018 at THE ROYAL CANADIAN MILITARY INSTITUTE, The Otter Room (4th Floor), 426 University Avenue, Toronto, Ontario M5G 1S9 at 2:00pm (Eastern Time), for the following purposes:

to receive the audited financial statements of the Company for the year ended April 30, 2018, and the report of the auditors thereon; to elect directors of the Company for the ensuing year; to re-appoint RSM Canada LLP (formerly Collins Barrow Toronto LLP) as auditors of the Company and to authorize the board of directors to fix their remuneration; to consider and, if thought advisable, to pass, with or without variation, a special resolution authorizing an amendment to the Company’s Articles to change the name of the Company to “Canada House Group Inc.”, “Canada House Cannabis Group Inc.” or such other name as the directors may approve; and to transact such other business as may properly come before the Meeting or any adjournment or postponement thereof.

The specific details of the foregoing matters to be put before the Meeting are set forth in the Management Proxy Circular that was mailed to shareholders in connection with the meeting.

Dress code throughout the Institute is business attire (jacket and tie for males or its equivalent for females). Worn or torn jeans, sweatshirts/suits, shorts and casual/beach sandals and apparel with bold slogans or commercial messages is not permitted. Military/Police/Firefighter/EMS dress shall be the “dress of the day” or any order of dress dictated by the relevant Dress Orders.

Only Shareholders of record at the close of business on September 25, 2018 are entitled to the notice of Meeting. Those Shareholders of record will be included in the list of Shareholders prepared as at the Record Date and will be entitled to vote the Common Shares recorded therein at the Meeting.

A Shareholder may attend the Meeting in person or may be represented by proxy. Shareholders who are unable to attend the Meeting or any adjournment or postponement thereof in person are requested to date, sign and return the accompanying form of proxy for use at the Meeting or any adjournment or postponement thereof. To be effective, such proxy must be received by the Corporation's transfer agent, Computershare Investor Services Inc., by 5:00 p.m. (Eastern time) on October 26, 2018, or two business days prior to the time of the reconvening of any adjournment or postponement of the Meeting.

If you are an unregistered holder of common shares of the Company and have received these materials through your broker, investment dealer, bank, trust corporation, trustee or other intermediary, please complete and return the form of proxy provided to you by your intermediary in accordance with the instructions provided therein.

If you require any assistance in completing your form of proxy, please contact Computershare Investor Services Inc. by calling toll free within North America at 1-800-564-6253 by e-mail at service@computershare.com.

For further information, please contact:

Boom Capital Markets

Steve Low

647-620-5101

steve@boomcapitalmarkets.com

Canada House Wellness Group Inc.

Chris Churchill-Smith, CEO

514-313-0102

chris.smith@canadahouse.ca

Cautionary Statement Regarding Forward Looking Information. This press release contains forward-looking statements, including statements that relate to, among other things, the Company’s clinic, production and technology businesses, its future plans, the Company’s markets, objectives, goals, strategies, intentions, beliefs, expectations and estimates, and can generally be identified by the use of words such as “may”, “will”, “could”, “should”, “would”, “likely”, “possible”, “expect”, “intend”, “estimate”, “anticipate”, “believe”, “plan”, “objective” and “continue” (or the negative thereof) and words and expressions of similar import. Although the Company believes that the expectations reflected in such forward-looking statements are reasonable, such statements involve risks and uncertainties, and undue reliance should not be placed on such statements. Certain material factors or assumptions are applied in making forward-looking statements, and actual results may differ materially from those expressed or implied in such statements. Material assumptions used to develop forward-looking information in this news release include, among other things, the regulations related to cannabis use under the Access to Cannabis for Medical Purposes Regulations and the act respecting cannabis and to amend the Controlled Drugs and Substances Act, the Criminal Code and other Acts, passed by the Canadian Federal government, making cannabis legal for recreational use by October 17, 2018; Company liquidity and capital resources, including the availability of additional capital resources to fund its activities; level of competition; the ability to adapt products and services to the changing market; the ability to attract and retain key executives; and the ability to execute strategic plans. Additional information about material factors that could cause actual results to differ materially from expectations and about material factors or assumptions applied in making forward-looking statements may be found in the Company’s most recent annual and interim Management’s Discussion and Analysis under “Risk and Uncertainties” as well as in other public disclosure documents filed with Canadian securities regulatory authorities. The Company does not undertake any obligation to update publicly or to revise any of the forward-looking statements contained in this document, whether as a result of new information, future events or otherwise, except as required by law.

Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.